Radionuclides for Targeted Therapy: Physical Properties

por Stokke, Caroline, Kvassheim, Monika, Blakkisrud, Johan
Publicado 2022

Correlations between [(68)Ga]Ga-DOTA-TOC Uptake and Absorbed Dose from [(177)Lu]Lu-DOTA-TATE

por Bruvoll, Ragnar, Blakkisrud, Johan, Mikalsen, Lars Tore, Connelly, James, Stokke, Caroline
Publicado 2023

FDG PET/CT and Dosimetric Studies of (177)Lu-Lilotomab Satetraxetan in a First-in-Human Trial for Relapsed Indolent non-Hodgkin Lymphoma—Are We Hitting the Target?

por Løndalen, Ayca, Blakkisrud, Johan, Revheim, Mona-Elisabeth, Dahle, Jostein, Kolstad, Arne, Stokke, Caroline
Publicado 2022

Pre-dosing with lilotomab prior to therapy with (177)Lu-lilotomab satetraxetan significantly increases the ratio of tumor to red marrow absorbed dose in non-Hodgkin lymphoma patien...

por Stokke, Caroline, Blakkisrud, Johan, Løndalen, Ayca, Dahle, Jostein, Martinsen, Anne C. T., Holte, Harald, Kolstad, Arne
Publicado 2018

FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of (177)Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma

por Løndalen, Ayca, Blakkisrud, Johan, Revheim, Mona-Elisabeth, Madsbu, Ulf Erik, Dahle, Jostein, Kolstad, Arne, Stokke, Caroline
Publicado 2020

Radiation safety considerations for the use of radium-224-calciumcarbonate-microparticles in patients with peritoneal metastasis

por Grønningsæter, Simen Rykkje, Blakkisrud, Johan, Selboe, Silje, Revheim, Mona-Elisabeth, Bruland, Øyvind Sverre, Bønsdorff, Tina Bjørnlund, Larsen, Stein Gunnar, Stokke, Caroline
Publicado 2023